Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- C3647 ML-211Summary: dual inhibitor of LYPLA1 and the related LYPLA2
- C3661 WWL123Summary: brain-penetrant inhibitor of ABHD6
- C3794 1-Naphthyl 3,5-dinitrobenzoateSummary: dual 5-lipoxygenase and microsomal prostaglandin E synthase-1 inhibitor
- C3762 Dimethyl DL-Glutamate (hydrochloride)Summary: cell-permeable form of glutamate
- C3768 5-hydroxy TryptopholSummary: metabolite of tryptophan
- C3777 L-Histidinol (hydrochloride)Summary: intermediate in the biosynthesis of the amino acid L-histidine
- C3779 Arachidonic Acid LeelamideSummary: phospholipase A2 inhibitor
- C3792 Oleyloxyethyl PhosphorylcholineSummary: PLA2 inhibitor
- C3853 NCT-503Summary: 3-phosphoglycerate dehydrogenase (PHGDH) inhibitor
- C4115 ML-095 (hydrochloride)Summary: placental alkaline phosphatase (PLAP) inhibitor